Praxis precision medicines receives orphan drug designation for prax-562 for the treatment of scn2a-dee

Prax-562 phase 2 clinical trial for treatment of dees expected to initiate in first half of 2022 prax-562 phase 2 clinical trial for treatment of dees expected to initiate in first half of 2022
PRAX Ratings Summary
PRAX Quant Ranking